NCT04169347 2023-07-27
FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Criterium, Inc.
Phase 2 Unknown
Clinical Trials
13 trialsNCT01801904 2023-03-24
PACER
National Cancer Institute, Naples
Phase 2 Unknown
NCT03751176 2021-06-30
BEYOND
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2 Unknown
NCT04668976 2020-12-21
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Benaroya Research Institute
Phase 2 Unknown
NCT02904031 2020-05-12
PANDA
Gruppo Oncologico del Nord-Ovest
Phase 2 Unknown
NCT02301962 2019-12-16
Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer
Dr. Reddy's Laboratories Limited
Phase 4 Unknown
NCT00647530 2019-05-17
FOxTROT
University of Birmingham
Phase 2/3 Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT02476045 2016-09-14
Valentino
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT01257360 2016-01-13
NEO-RIT
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2 Unknown
NCT00967655 2014-01-10
Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01110785 2013-09-17
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01144195 2010-11-10
ACTIVE
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials
Phase 2 Unknown